Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Myoblast transplantations lead to the expression of the laminin α2 chain in normal and dystrophic (dy/dy) mouse muscles

Gene Therapy volume 6, pages 792–800 (1999)Cite this article

Abstract

Laminin-2 is part of the basement membrane of the skeletal muscle fibers. The laminin α2 chain is absent or drastically reduced in a subgroup of congenital muscular dystrophy patients, and in the severely affected dystrophic dy/dy mouse. We previously reported that heterogenous primary mouse muscle cell cultures conferred laminin α2 chain expression in dy/dy mice muscles upon cell transplantation. In the present study we investigated whether pure myoblast cell lines were able to confer laminin α2 chain expression in vivo. We observed that: (1) xenotransplantation of non-immortalized human myoblast in SCID mouse muscles allows human laminin α2 chain expression; (2) allotransplantation of the permanent G8 mouse myoblast cell line in dy/dy muscles allows the expression of the murine laminin α2 chain; and (3) allotransplantation of the D7 dystrophic dy/dy cell line allows the formation of new and hybrid muscle fibers in dy/dy muscle in the absence of laminin α2 chain expression. We conclude that normal myoblasts are able to restore the expression of an extracellular skeletal muscle protein and that the absence of laminin-2 does not prevent transplanted muscle cells from participating in the formation of myofibers. Myoblasts are, therefore, attractive tools for further exploration of gene complementation strategies in the animal models of congenital muscular dystrophy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Leivo I, Engvall E . Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is expressed late in nerve and muscle development Proc Natl Acad Sci USA 1988 85: 1544–1548

    Article  CAS  Google Scholar 

  2. Ehrig K et al. Merosin, a tissue-specific basement membrane protein, is a laminin-like protein Proc Natl Acad Sci USA 1990 87: 3264–3268

    Article  CAS  Google Scholar 

  3. Vuolteenaho R et al. Human laminin M chain (merosin): complete primary structure, chromosomal assignment, and expression of the M and A chain in human fetal tissues J Cell Biol 1994 124: 381–394

    Article  CAS  Google Scholar 

  4. Schuler F, Sorokin LM . Expression of laminin isoforms in mouse myogenic cells in vitro and in vivo J Cell Sci 1995 108: 3795–3805

    CAS  PubMed  Google Scholar 

  5. Sewry CA et al. Diagnosis of merosin (laminin-2) deficient congenital muscular dystrophy by skin biopsy Lancet 1996 347: 582–584

    Article  CAS  Google Scholar 

  6. Burgeson RE et al. A new nomenclature for the laminins Matrix Biol 1994 14: 209–211

    Article  CAS  Google Scholar 

  7. Engvall E, Wewer UM . Domains of laminin J Cell Biochem 1996 61: 493–501

    Article  CAS  Google Scholar 

  8. Campbell KP . Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage Cell 1995 80: 675–679

    Article  CAS  Google Scholar 

  9. Patton BL, Miner JH, Chiu AI, Sanes JR . Distribution and function of laminins in the neuromuscular system of developing, adult, and mutant mice J Cell Biol 1997 139: 1507–1521

    Article  CAS  Google Scholar 

  10. Vachon PH et al. Merosin and laminin in myogenesis; specific requirement for merosin in myotube stability and survival J Cell Biol 1996 134: 1483–1498

    Article  CAS  Google Scholar 

  11. Kuang W, Xu H, Vachon PH, Engvall E . Disruption of the lama2 gene in embryonic stem cells; laminin α2 is necessary for sustenance of mature muscle cells Exp Cell Res 1998 241: 117–125

    Article  CAS  Google Scholar 

  12. Tomé FMS et al. Congenital muscular dystrophy with merosin deficiency CR Acad Sci Paris 1994 317: 351–357

    Google Scholar 

  13. Helbling-Leclerc A et al. Mutations in the laminin α2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy Nat Genet 1995 11: 216–218

    Article  CAS  Google Scholar 

  14. Nissinen M et al. Substitution of a conserved cysteine-996 in a cysteine-rich motif of the laminin α2 chain in congenital muscular dystrophy with partial deficiency of the protein Am J Hum Genet 1996 58: 1177–1184

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Zhang X, Vuolteenaho R, Tryggvason K . Structure of the human laminin alpha2-chain gene (LAMA2), which is affected in congenital muscular dystrophy J Biol Chem 1996 271: 27664–27669

    Article  CAS  Google Scholar 

  16. Michelson AM, Russell ES, Harman PJ . Dystrophia muscularis: a hereditary primary myopathy in the house mouse Proc Natl Acad Sci USA 1955 41: 1079–1084

    Article  CAS  Google Scholar 

  17. Arahata A et al. Laminin in animal models for muscular dystrophy. Defect of laminin M in skeletal and cardiac muscles and peripheral nerve of the homozygous dystrophic dy/dy mice Proc Jpn Acad 1993 69: 259–264

    Article  Google Scholar 

  18. Sunada Y et al. Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus J Biol Chem 1994 269: 13729–13732

    CAS  PubMed  Google Scholar 

  19. Xu H et al. Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse Proc Natl Acad Sci USA 1994 91: 5572–5576

    Article  CAS  Google Scholar 

  20. Meier H, Southard JL . Muscular dystrophy in the mouse caused by an allele at the dylocus Life Sci 1970 9: 137–144

    Article  CAS  Google Scholar 

  21. Xu H, Wu XR, Wewer UM, Engvall E . Murine muscular dystrophy caused by a mutation in the laminin α2 (Lama2) gene Nat Genet 1994 8: 297–302

    Article  CAS  Google Scholar 

  22. Sunada Y et al. Identification of a novel mutant transcript of laminin α2 chain gene responsible for muscular dystrophy and dysmyelination in dy2J/dy2J mice Hum Mol Genet 1995 4: 1055–1061

    Article  CAS  Google Scholar 

  23. Miyagoe Y et al. Laminin α2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy FEBS Lett 1997 415: 33–39

    Article  CAS  Google Scholar 

  24. Kuang W et al. Merosin-deficient congenital muscular dystrophy; partial genetic correction in two mouse models J Clin Invest 1998 102: 844–852

    Article  CAS  Google Scholar 

  25. Vilquin JT et al. Partial laminin α2 chain restoration in laminin α2 chain-deficient dy/dy mouse by primary muscle cell culture transplantation J Cell Biol 1996 133: 185–197

    Article  CAS  Google Scholar 

  26. Haider SR, Wang W, Kaufman SJ . SV40 T antigen inhibits expression of MyoD and myogenin, up-regulates Myf-5, but does not affect early expression of desmin or α7 integrin during muscle development Exp Cell Res 1994 210: 278–286

    Article  CAS  Google Scholar 

  27. Tedesco D, Caruso M, Fischer-Fantuzzi L, Vesco C . The inhibition of cultured myoblast differentiation by the simian virus 40 large T antigen occurs after myogenin expression and Rb up-regulation and is not exerted by transformation-competent cytoplasmic mutants J Virol 1995 69: 6947–6957

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Christian CN, Nelson PG, Peacock J, Nirenberg M . Synapse formation between two clonal cell lines Science 1977 196: 995–998

    Article  CAS  Google Scholar 

  29. Yaffe D, Saxel O . Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle Nature 1977 270: 725–727

    Article  CAS  Google Scholar 

  30. Tremblay JP et al. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy Cell Transplant 1993 2: 99–112

    Article  CAS  Google Scholar 

  31. Huard J et al. High efficacy of muscle regeneration following human myoblast transplantation in SCID mice J Clin Invest 1994 93: 586–599

    Article  CAS  Google Scholar 

  32. Adam M, Ramesh N, Miller DA, Osborne WRA . Internal initiation of translation in retroviral vectors carrying picornavirus 5′ nontranslated regions J Virol 1991 65: 4985–4990

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Kinoshita I et al. Very efficient myoblast allotransplantation in mice under FK506 immunosuppression Mus Nerve 1994 17: 1407–1415

    Article  CAS  Google Scholar 

  34. Kinoshita I et al. Transplantation of myoblasts from a transgenic mouse overexpressing dystrophin produced only a relatively small increase of dystrophin positive membrane Mus Nerve 1997 21: 91–103

    Article  Google Scholar 

  35. Berndt A, Kosmehl H, Katenkamp D, Tauchmann V . Appearance of the myofibroblastic phenotype in Dupuytren’s disease is associated with a fibronectin, laminin, collagen type IV and tenascin extracellular matrix Pathobiology 1994 62: 55–58

    Article  CAS  Google Scholar 

  36. Hagg T, Portera-Cailliau C, Jucker M, Engvall E . Laminins of the adult mammalian CNS; laminin-α2 (merosin M−) chain immunoreactivity is associated with neuronal processes Brain Res 1997 764: 17–27

    Article  CAS  Google Scholar 

  37. Partridge TA et al. Conversion of mdx myofibres from dystrophin-negative to-positive by injection of normal myoblasts Nature 1989 337: 176–179

    Article  CAS  Google Scholar 

  38. Morgan JE, Hoffman EP, Partridge TA . Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse J Cell Biol 1990 111: 2437–2449

    Article  CAS  Google Scholar 

  39. Vilquin JT et al. Successful histocompatible myoblast transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin J Cell Biol 1995 131: 975–988

    Article  CAS  Google Scholar 

  40. Guérette B et al. Immunosuppression with monoclonal antibodies and CTLA4-Ig after myoblast transplantation in mice Transplantation 1996 62: 962–967

    Article  Google Scholar 

  41. Guérette B et al. Prevention by anti-LFA-1 of acute myoblast death following transplantation J Immunol 1997 159: 2522–2531

    PubMed  Google Scholar 

  42. Qu Z et al. Development of approaches to improve cell survival in myoblast transfer therapy J Cell Biol 1998 142: 1257–1267

    Article  CAS  Google Scholar 

  43. Floyd SS et al. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles Gene Therapy 1998 5: 19–30

    Article  CAS  Google Scholar 

  44. Moisset PA et al. Successful transplantation of genetically corrected DMD myoblasts following ex vivo transduction with the dystrophin minigene Biochem Biophys Res Com Mun 1998 247: 94–99

    Article  CAS  Google Scholar 

  45. Merly F et al. Anti-inflammatory effect of transforming growth factor-betal in myoblast transplantation Transplantation 1998 65: 793–799

    Article  CAS  Google Scholar 

  46. Kinoshita I, Vilquin JT, Tremblay JP . Pretreatment of myoblast cultures with basic fibroblast growth factor increases the efficacy of their transplantation in mdx mice Mus Nerve 1995 18: 834–841

    Article  CAS  Google Scholar 

  47. Kinoshita I, Vilquin JT, Roy R, Tremblay JP . Successive injections in mdx mice of myoblasts grown with a high concentration of bFGF Neuromusc Dis 1996 6: 187–193

    Article  CAS  Google Scholar 

  48. Ito H, Hallauer PL, Hastings KE, Tremblay JP . Prior culture with concanavalin A increases intramuscular migration of transplanted myoblasts Mus Nerve 1998 21: 291–297

    Article  CAS  Google Scholar 

  49. Webster C et al. Isolation of human myoblasts with the fluorescence-activated cell sorter Exp Cell Res 1988 174: 252–265

    Article  CAS  Google Scholar 

  50. Wernig A et al. Formation of new muscle fibres and tumours after injection of cultured myogenic cells J Neurocytol 1991 20: 982–997

    Article  CAS  Google Scholar 

  51. Koelle GB, Friedenwald JS . A histochemical method for localizing cholinesterase activity Proc Soc Exp Biol Med 1949 70: 617–622

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unité de Médecine Génétique et Moléculaire, Centre Hospitalier de l’Université, Laval, Québec, Canada

    J-T Vilquin, B Guérette, J Puymirat & J P Tremblay

  2. INSERM U 523, Hôpital de la Salpétrière, Paris, France

    J-T Vilquin, F M S Tomé, M Fardeau, M Fiszman & K Schwartz

  3. Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel

    D Yaffe

Authors
  1. J-T Vilquin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B Guérette
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J Puymirat
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D Yaffe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F M S Tomé
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M Fardeau
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M Fiszman
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. K Schwartz
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. J P Tremblay
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vilquin, JT., Guérette, B., Puymirat, J. et al. Myoblast transplantations lead to the expression of the laminin α2 chain in normal and dystrophic (dy/dy) mouse muscles. Gene Ther 6, 792–800 (1999). https://doi.org/10.1038/sj.gt.3300889

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3300889

Keywords

This article is cited by

Search

Advanced search

Quick links